« Back to the previous page

Also available in:

Buyer for an oncology CRO in Europe

Company to buy

  • Size: small sized business
  • Revenue: 3 – 10 million EUR
  • Location of the target company: any country of Europe
  • Reason for acquisition: The company ants to add external growth to organic growth
  • #CFIE PHB057

Overview of this buyer for an oncology CRO 

A profitable CRO based in the Benelux region, which expanded its services organically in the recent past, is now looking to purchase a similar-sized company as part of its continuing expansion plans. The company is looking at any European country with a stable portfolio of customers and a positive growth outlook.

Profile (strategy) of this oncology CRO buyer

The buyer is a well-established management, consultancy and contract research company based in Europe, specialized in serving top clients in the pharmaceutical industry and healthcare sector. The company serves governmental institutions, but also private companies. The company is operating on a European level, having offices in multiple countries of Europe.

The company is providing professional services in areas such as:

  • medical consultancy
  • medical device consulting
  • clinical research
  • clinical studies
  • drug development consultancy etc.

The company is an expert in multiple disciplines, such as:

  • Oncology
  • Ophthalmology
  • Haematology
  • Cardiology
  • Immunology
  • Gastroenterology
  • Respiratory diseases and many more.
Contact this buyer of a pharma CRO company

Contact us to get details about this buyer of oncology CRO companies now

Activities and products of an ideal target CRO

This buyer company is planning to grow externally by M&A in the near future, which would boost the growth of the services portfolio. Therefore, they are looking for a CRO company in Europe, in order to acquire or merge. It would be ideal if the CRO had experience with oncology or similar discipline.

Geographically, the buyer is looking at all countries and will be willing to consider any country, but central Europe, countries like Germany or Austria will be preferred.

The target should be experienced and have a good track record. The current management would stay in place preferably after the acquisition. The current revenue or financials of the company are not as decisive, on the other hand, the target should not be in loss or in significant debt. It is important to have a professional team with a successful project history.

Highlights of this contract research organization buyer

  • The buyer is a CRO company looking for targets which could help them with expansion in Europe
  • The target company should be any contract research organization (CRO) in Europe with a good track record 
  • The buyer is open to a full acquisition or a majority investment, the structure can be a subject of discussion

Information about this buyer of CRO in Europe

Feel free to contact us for more information regarding this pharma contract research organization (CRO) buyer in Europe, or if you know possible interested or suitable parties. For more buyers of pharmaceutical companies, please visit the section pharmaceutical companies wanted. For pharmaceutical companies for sale visit the section pharmaceutical companies for sale



Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual please explain as much as possible about your personal background strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.